over 7 years ago // Sponsored by Novartis
A new independent policy study, commissioned by Novartis, reveals controversial views about what African experts think is the best way to push forward progress on malaria eliminations. This guest column details the biggest findings of the Malaria Futures for Africa, or MalaFA study, and explains why we need to take advantage of these African insights and learnings.